Clinical Decision and Support Systems have progressed at a breakneck pace. They are now widely administered through electronic medical records and other automated clinical procedures, which has been made possible by the growing global usage of advanced electronic medical records. Despite these advancements, there are still questions about the impact of Clinical Decision and Support Systems on providers, patient outcomes, and costs. There have been numerous reported examples of Clinical Decision and Support System success stories over the last decade(s), yet major setbacks have also revealed that CDSS are not without danger.
Clinical decision support systems have been shown to
be helpful in reducing the number of days spent in hospitals, reducing hospital
readmissions, preventing medical errors, and adverse events caused by clinical
decisions, according to a report published by the Healthcare Information and
Management Systems Society in 2011. The advantages that clinical decision
support systems provide are likely to promote its adoption among end users,
resulting in market growth for clinical decision support systems. The global clinical
decision support system market is expected to exhibit a CAGR of 11.69% over the forecast
period,
Market players are forming strategic alliances and
using one another's strengths to develop new products. Cerner and Lumeris
formed a 10-year strategic partnership in July 2018 to bring answers to the
present health-care system's inefficiencies. Two firms would launch a product
called Maestro Advantage as a result of this collaboration. This new solution
would combine existing investments in digitised data and procedures to give
actionable data and insights into healthcare provider workflows.